Response to the ACMD on GHB, GBL and closely related compounds
The government responds to the Advisory Council on the Misuse of Drugs on its assessment of the harms of GHB and GBL.
Documents
Details
These letters from the government are in response to the assessment provided by the Advisory Council on the Misuse of Drugs (ACMD) of the harms of gamma-hydroxybutyric acid, gamma-butyrolactone, and closely related compounds.
Updates to this page
Last updated 27 April 2022 + show all updates
-
Added further government response to ACMD's report - 'Letter from the Minister of State for Crime, Policing and Probation to the Chair of the Advisory Council on the Misuse of Drugs'.
-
First published.